Mentice AB (publ) (STO:MNTC)

Market Cap	428.92M +55.6%
Revenue (ttm)	303.13M +15.9%
Net Income	-4.61M
EPS	-0.16
Shares Out	28.13M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8,823
Open	15.50
Previous Close	15.50
Day's Range	15.25 - 15.55
52-Week Range	9.34 - 18.95
Beta	0.50
Analysts	n/a
Price Target	22.75 (+49.18%)
Earnings Date	Nov 10, 2026

About Mentice AB

Mentice AB (publ), together with its subsidiaries, develops, sells, and markets solutions for training and decision support in the clinical area of interventional angiography in cardiology, neurology, vascular surgery, and radiology. It operates through the Mentice VIST, Physical Sim, and Ankyras segments. The company offers virtual simulation products, including VR simulator platforms; procedural learning models; peripheral vascular; patient simulator accessories and extensions for endovascular therapies; and Angiosuite integrations, such as t...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1998
• Employees: 109
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: MNTC

Financial Performance

In 2025, Mentice AB's revenue was 279.09 million, a decrease of -3.87% compared to the previous year's 290.33 million. Losses were -32.33 million, 75.5% more than in 2024.

Analyst Summary

The average 12-month stock price target for MNTC is kr 22.75, which is an increase of 49.18% from the latest price.

Price Target

kr 22.75

(49.18% upside)

Data Sources: S&P Global Market Intelligence and QUODD

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by QUODD.

Last checked:

Nov 4, 2026

Data Sources Report a data error